February 22, 2023
5 min watch
Save
VIDEO: Jeanne Marrazzo, MD, MPH, on PrEP adherence in cisgender women
Issue: March 2023
You've successfully added to your alerts. You will receive an email when new content is published.
Click Here to Manage Email Alerts
Click Here to Manage Email Alerts
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.
SEATTLE — In this video, Jeanne M. Marrazzo, MD, MPH, director of the division of infectious diseases at the University of Alabama at Birmingham School of Medicine, talks about PrEP adherence and efficacy in cisgender women.
An analysis of data from more than 6,000 women collected over nearly a decade in sub-Saharan Africa and Asia found that for most, adherence declined over time.
“We obviously need other options for women who want to initiate PrEP — they’re really urgently needed,” said Marrazzo, an Infectious Disease News Editorial Board Member.
Published by:
Sources/Disclosures
Collapse
Disclosures:
Marrazzo reports receiving consulting/advisory fees from Merck.
Read more about
You've successfully added to your alerts. You will receive an email when new content is published.
Click Here to Manage Email Alerts
Click Here to Manage Email Alerts
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.